More articles from Mini Review

Epitranscriptome of Noncoding RNAs
Manel Esteller, Pier Paolo Pandolfi

Cancer Discovery Apr 2017, 7 (4) 359-368; DOI: 10.1158/2159-8290.CD-16-1292
Precision Immunotherapy
Rajarsi Mandal, Timothy A. Chan

Cancer Discovery Jul 2016, 6 (7) 703-713; DOI: 10.1158/2159-8290.CD-16-0146
Adaptive Immune Resistance
Antoni Ribas

Cancer Discovery Sep 2015, 5 (9) 915-919; DOI: 10.1158/2159-8290.CD-15-0563
Targeting TRK Oncogenes in Cancer
Aria Vaishnavi, Anh T. Le, Robert C. Doebele

Cancer Discovery Jan 2015, 5 (1) 25-34; DOI: 10.1158/2159-8290.CD-14-0765
Novel Adenosine-Based Cancer Therapeutics
Arabella Young, Deepak Mittal, John Stagg, Mark J. Smyth

Cancer Discovery Aug 2014, 4 (8) 879-888; DOI: 10.1158/2159-8290.CD-14-0341
Autophagy Inhibition in BRAF-Driven Cancers
Anne M. Strohecker, Eileen White

Cancer Discovery Jul 2014, 4 (7) 766-772; DOI: 10.1158/2159-8290.CD-14-0196
Mechanisms of Resistance to PI3K/AKT/mTOR Inhibitors
Samuel J. Klempner, Andrea P. Myers, Lewis C. Cantley

Cancer Discovery Dec 2013, 3 (12) 1345-1354; DOI: 10.1158/2159-8290.CD-13-0063
ceRNAs and Cancer
Florian A. Karreth, Pier Paolo Pandolfi

Cancer Discovery Oct 2013, 3 (10) 1113-1121; DOI: 10.1158/2159-8290.CD-13-0202
ARID1A Mutations in Cancer
Jennifer N. Wu, Charles W.M. Roberts

Cancer Discovery Jan 2013, 3 (1) 35-43; DOI: 10.1158/2159-8290.CD-12-0361
Treatment of Pancreatic Neuroendocrine Tumors
Jaume Capdevila, Josep Tabernero

Cancer Discovery Aug 2011, 1 (3) 213-221; DOI: 10.1158/2159-8290.CD-11-0151

Main menu